{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:17:40Z","timestamp":1771543060960,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Inflammation occurs in the initial stage of arterial atherosclerosis and serves as the first step in thrombus generation, with elevated inflammatory markers predicting myocardial infarction in coronary artery disease patients. Inflammation is known to alter the course of multiple diseases and can thus, also impact recovery post-treatment and surgical outcomes. Yet, there is a paucity of data regarding the relationship between inflammatory biomarkers and arterial thrombotic potential in peripheral artery disease (PAD) patients post-revascularization. Our pilot study attempts to fill this gap by evaluating if the expression of inflammatory biomarkers in PAD patients correlates with the incidence of thrombotic events post-revascularization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Plasma samples were prospectively collected from PAD patients who underwent revascularization from 2021 to 2023 at monthly time points for 6\u202fmonths from the procedure. Patients were followed for a total of 6\u202fmonths post-procedure and those who experienced thrombotic events were identified. Nine patients with thrombotic events and 16 with non-thrombotic events along with 5 healthy volunteers were analyzed. Plasma samples were analyzed for the following pro-inflammatory markers: IL-1\u03b2 (Interleukin-1 beta), IL-6, and TNF-<jats:italic>\u03b1<\/jats:italic> (Tumor Necrosis Factor - alpha), GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor), IFN\u03b3 (Interferon-gamma), IL-8, MCP-1 (Monocyte Chemoattractant Protein-1). The Kruskal-Wallis test was performed to compare bio-inflammatory marker levels between groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 303 patients were enrolled, of which 59 had thrombotic events. There were no differences between medications or disease burden between groups. Levels of circulating IL-6 and TNF- <jats:italic>\u03b1<\/jats:italic> were significantly higher in the thrombosis cohort compared to the non-thrombosis cohort (55 vs. 38, <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.02) and (159 vs. 110, <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.02) respectively. Although there was a trend toward significance for IL-1\u03b2 between the thrombotic cohort and non-thrombotic cohort, it did not reach statistical significance (18 vs. 11.5, <jats:italic>p<\/jats:italic> =\u202fNS). There was no difference observed in aspirin\u2019s ability to dampen the inflammatory response between the two groups as all patients were on aspirin between the groups evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pro-inflammatory markers IL-6 and TNF-<jats:italic>\u03b1<\/jats:italic> are significantly increased in patients, 1\u202fmonth prior to an arterial thrombotic event, as compared to patients without thrombotic events. These biomarkers could predict impending thrombosis in patients with PAD post-revascularization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1615816","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T05:34:19Z","timestamp":1753335259000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization"],"prefix":"10.3389","volume":"12","author":[{"given":"Adriana A.","family":"Rodriguez Alvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella F.","family":"Cieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounika Naidu","family":"Boya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniket","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasha P. Suarez","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christianah","family":"Alli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anahita","family":"Dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"Fowkes","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"ref2","year":"2024"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","article-title":"Peripheral arterial disease: morbidity and mortality implications","volume":"114","author":"Golomb","year":"2006","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.semvascsurg.2022.04.001","article-title":"Peripheral artery disease: where we are and where we are going","volume":"35","author":"Morrow","year":"2022","journal-title":"Semin Vasc Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2174\/138161212799504731","article-title":"Inflammation-induced thrombosis: mechanisms, disease associations and management","volume":"18","author":"Aksu","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/bmb\/ldr043","article-title":"Inflammatory markers in coronary heart disease","volume":"100","author":"Madjid","year":"2011","journal-title":"Br Med Bull"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5493\/wjem.v5.i1.21","article-title":"Consolidated and emerging inflammatory markers in coronary artery disease","volume":"5","author":"Lubrano","year":"2015","journal-title":"World J Exp Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2796.2002.01019.x","article-title":"Inflammatory bio-markers and cardiovascular risk prediction","volume":"252","author":"Blake","year":"2002","journal-title":"J Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.cir.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jjcc.2008.12.007","article-title":"Inflammatory biomarkers in coronary artery disease","volume":"53","author":"Zakynthinos","year":"2009","journal-title":"J Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2147\/TCRM.S107635","article-title":"The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease","volume":"12","author":"Paquissi","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.2174\/138161212802481273","article-title":"Inflammation in peripheral arterial disease (PAD)","volume":"18","author":"Signorelli","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2015.01.021","article-title":"Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease","volume":"239","author":"Rein","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref16","year":""},{"key":"ref17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ahj.2009.04.014","article-title":"Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease","volume":"158","author":"Subramaniyam","year":"2009","journal-title":"Am Heart J"},{"key":"ref18","first-page":"267","article-title":"Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease","volume":"11","author":"Enayati","year":"2015","journal-title":"ARYA Atheroscler"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e0254606","DOI":"10.1371\/journal.pone.0254606","article-title":"Physiologically relevant aspirin concentrations trigger immunostimulatory cytokine production by human leukocytes","volume":"16","author":"Brox","year":"2021","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.104.513085","article-title":"C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh artery study","volume":"112","author":"Tzoulaki","year":"2005","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.3390\/ijms231912054","article-title":"Inflammatory and Prothrombotic biomarkers, DNA polymorphisms, MicroRNAs and personalized medicine for patients with peripheral arterial disease","volume":"23","author":"Poredo\u0161","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"10740","DOI":"10.1038\/s41598-019-47217-1","article-title":"A pro-inflammatory biomarker-profile predicts amputation-free survival in patients with severe limb ischemia","volume":"9","author":"Gremmels","year":"2019","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/01.cir.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"100396","DOI":"10.1016\/j.xcrm.2021.100396","article-title":"Blocking endogenous IL-6 impairs mobilization of free fatty acids during rest and exercise in lean and obese men","volume":"2","author":"Trinh","year":"2021","journal-title":"Cell Rep Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1615816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T05:34:20Z","timestamp":1753335260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1615816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":24,"alternative-id":["10.3389\/fmed.2025.1615816"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1615816","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"article-number":"1615816"}}